Breaking News Instant updates and real-time market news.

MS

Morgan Stanley

$32.39

-0.17 (-0.52%)

, BAC

Bank of America

$16.22

0.11 (0.68%)

07:53
10/07/16
10/07
07:53
10/07/16
07:53

Banks speed up contingency planning for possible 'hard Brexit,' WSJ says

British-based banks are accelerating contingency planning for life after the European Union as British Prime Minister Theresa May pledges to prioritize controlling immigration in the coming Brexit negotiations and politicians on the other side increase their rhetoric about being tough on the U.K. in the exit accords, reported The Wall Street Journal. Morgan Stanley (MS) is crafting plans on the basis of a worst-case scenario of a breakaway from the EU, a person familiar with the plan tells the Journal, while Lloyds Banking (LYG) executives are considering ways to create a subsidiary in Europe, the report added. Other big U.S. banks include Bank of America (BAC), Citi (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS) and Wells Fargo (WFC). Other big U.K. banks include Barclays (BCS) and RBS (RBS). Reference Link

MS

Morgan Stanley

$32.39

-0.17 (-0.52%)

BAC

Bank of America

$16.22

0.11 (0.68%)

GS

Goldman Sachs

$167.15

0.75 (0.45%)

C

Citi

$49.07

0.42 (0.86%)

JPM

JPMorgan

$67.87

0.18 (0.27%)

BCS

Barclays

LYG

Lloyds Banking

$2.82

-0.02 (-0.70%)

RBS

RBS

WFC

Wells Fargo

$45.18

0.19 (0.42%)

  • 14

    Oct

  • 14

    Oct

  • 19

    Oct

  • 21

    Oct

  • 23

    Oct

  • 26

    Oct

  • 03

    Nov

  • 10

    Nov

  • 28

    Feb

  • 14

    Jul

  • 12

    Oct

MS Morgan Stanley
$32.39

-0.17 (-0.52%)

07/13/16
BREN
07/13/16
INITIATION
Target $29
BREN
Hold
Morgan Stanley initiated with a Hold at Berenberg
Target $29.
10/06/16
SDLR
10/06/16
DOWNGRADE
Target $33
SDLR
Hold
Morgan Stanley downgraded to Hold from Buy at Sandler O'Neill
Sandler O'Neill analyst Jeffery Harte downgraded Morgan Stanley to Hold citing relative share outperformance and maintained his $33 price target on shares.
06/01/16
06/01/16
NO CHANGE

BMO Capital recommends pair trade ahead of CCAR
BMO Capital recommends that investors go long Discover (DFS) and Morgan Stanley (MS) and short Comerica (CMA) and Fifth Third (FITB) ahead of the release of the 2016 CCAR results. BMO says that, after analyzing the stress tests criteria, it prefers banks with less asset sensitivity, limited exposure to capital markets, limited exposure to business outside the U.S., low market expectations for pay-out ratio increases, and high starting capital ratios. For investors expecting an intreest rate hike in June, BMO recommends going long SunTrust (STI) and shorting Comerica and Fifth Third.
07/13/16
07/13/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Citi (C) initiated with a Buy, JPMorgan (JPM) initiated with a Sell, Goldman Sachs (GS) and Morgan Stanley (MS) initiated with a Hold at Berenberg. 2. Ingersoll-Rand (IR) initiated with an Outperform at BMO Capital. 3. Incyte (INCY) initiated with an Outperform at RBC Capital. 4. Williams (WMB) reinstated with a Buy at Goldman. 5. E-Trade (ETFC) initiated with a Buy at Buckingham. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
BAC Bank of America
$16.22

0.11 (0.68%)

09/13/16
SOCG
09/13/16
DOWNGRADE
Target $42
SOCG
Sell
Societe Generale cuts Citi to Sell, Bank of America to Hold
Societe Generale downgraded Citi (C) to Sell from Hold and Bank of America (BAC) to Hold from Buy. The firm has a $42 price target for shares of Citi and attributes an increased negative stance on Cards for the downgrade. Societe Generale has a $17 price target for Bank of America and cites revenue growth for the downgrade to Hold. Citi is trading down 86c to $46.93 and Bank of America is trading down 19c to $15.71.
08/25/16
GSCO
08/25/16
NO CHANGE
Target $17
GSCO
Buy
Bank of America at an inflection point, says Goldman
Goldman analyst Richard Ramsden believes Bank of America's operating leverage is at an inflection point as revenue growth and cost reductions from back office rationalization take effect. Ramsden met with CEO Moynihan and said he believes the company can grow core loans, without compromising credit quality, at mid-single digit rates, and expects the fee-based businesses to benefit from growth in checking accounts, mortgage activity, and market share gains. Ramsden believes Bank of America can achieve 10% ROTCE and views valuation as compelling. He rates shares a Buy with a $17 price target.
09/16/16
GSCO
09/16/16
NO CHANGE
Target $19
GSCO
Conviction Sell
Bank of America operating leverage hitting an inflection, says Goldman
Goldman analyst Richard Ramsden believes Bank of America is hitting an inflection point in operating leverage driven by low single digit growth, stable credit, and absolute reductions in the expense base. The analyst believes topline growth will reach approximately 4% annually through to 2018, driven by consumer bank and wealth management initiatives. Ramsden reiterates his Conviction Buy rating on Bank of American and raised his price target to $19 from $17 given the combination of revenue growth and expense discipline.
09/13/16
SOCG
09/13/16
DOWNGRADE
SOCG
Hold
Bank of America downgraded to Hold from Buy at Societe Generale
GS Goldman Sachs
$167.15

0.75 (0.45%)

04/19/16
SBSH
04/19/16
NO CHANGE
Target $185
SBSH
Buy
Goldman Sachs offers the best risk/reward under coverage, says Citi
Citi analyst Keith Horowitz said Goldman Sachs offers the best risk/reward under coverage and sees significant leverage for better returns from improved market conditions and increased expense focus. The analyst rates Goldman Sachs a Buy with a $185 price target.
07/13/16
BREN
07/13/16
INITIATION
Target $140
BREN
Hold
Goldman Sachs initiated with a Hold at Berenberg
Target $140.
03/16/16
LYON
03/16/16
NO CHANGE
LYON
CLSA Technical Research says to Sell Bank of America, Goldman Sachs
CLSA Technical Research said market touched key overhead resistance provided by their 200-day moving averages last week, the majority of markets remain below these key technical resistance levels. CLSA believes the financials in particular look vulnerable after their relief rallies ran into major overhead resistance and recommends selling Bank of America (BAC) and Goldman Sachs (GS).
C Citi
$49.07

0.42 (0.86%)

09/16/16
GSCO
09/16/16
DOWNGRADE
GSCO
Neutral
Citi downgraded to Neutral from Buy at Goldman
Goldman analyst Richard Ramsden downgraded Citi to Neutral and lowered his price target on the shares to $50 from $52. The analyst said Citi's expected earnings inflection has failed to materialize and ROEs are at 7.7%, well below management's 10% target. Ramsden's analysis suggests growth in higher return businesses, such as credit cards and wealth management, and expense discipline will not be enough to increase ROE all the way to its 10% target. Citi remains a capital returns story, constrained by the utilization of deferred tax assets, the analyst wrote in his report.
09/13/16
SOCG
09/13/16
DOWNGRADE
SOCG
Sell
Citi downgraded to Sell from Hold at Societe Generale
09/16/16
09/16/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. 21st Century Fox (FOX, FOXA) downgraded to Market Perform from Outperform at Bernstein with analyst Jason Park citing a reduction in his estimates for the company's Star India business. 2. Wells Fargo (WFC) downgraded to Underweight from Neutral at Atlantic Equities. 3. Citi (C) downgraded to Neutral from Buy at Goldman with analyst Richard Ramsden saying Citi's expected earnings inflection has failed to materialize and ROEs are at 7.7%, well below management's 10% target. 4. McCormick (MKC) downgraded to Market Perform from Outperform at Bernstein with analyst Alexia Howard citing valuation. 5. Novavax (NVAX) downgraded to Neutral from Overweight at Piper Jaffray, to Neutral from Overweight at JPMorgan, to Neutral from Buy at Ladenburg, to Neutral from Outperform at Wedbush, and to Neutral from Buy at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
JPM JPMorgan
$67.87

0.18 (0.27%)

09/09/16
09/09/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. JPMorgan (JPM) downgraded to Neutral from Outperform at Macquarie with analyst David Konrad citing valuation. 2. CarMax (KMX) downgraded to Neutral from Buy at Buckingham with analyst Glenn Chin citing valuation. 3. Eaton (ETN) and Ingersoll-Rand (IR) downgraded to Sector Weight from Overweight at KeyBanc with analyst Jeffrey Hammond citing his more cautious outlook for nonresidential construction. 4. Estee Lauder (EL) downgraded to Hold from Buy at Argus with analyst John Staszak saying it will be difficult for the company to achieve further market share gains, given increased competition, slowing growth in the premium beauty products space, and a "challenging" macro environment. 5. SAIC (SAIC) downgraded to Market Perform from Outperform at Cowen and to Hold from Buy at Drexel Hamilton. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/06/16
SDLR
10/06/16
DOWNGRADE
Target $72
SDLR
Hold
JPMorgan downgraded to Hold from Buy at Sandler O'Neill
Sandler O'Neill analyst Jeffery Harte downgraded JPMorgan to Hold citing relative share outperformance and maintained his $72 price target on shares.
09/28/16
DBAB
09/28/16
UPGRADE
Target $11.5
DBAB
Buy
Huntington Bancshares upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Matt O'Connor upgraded Huntington Bancshares to Buy saying the 15% pullback in the shares since the FirstMerit (FMER) deal was announced is overdone. The analyst views industry-wide concerns surrounding consumer indirect auto lending as overblown and he raised his price target for Huntington shares to $11.50 from $10.50. Going into the Q3 results for U.S. banks, O'Connor likes JPMorgan (JPM) and Wells Fargo (WFC) and is cautious on Fifth Third (FITB).
10/06/16
10/06/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Tesla (TSLA) downgraded to Neutral from Buy at Goldman with analyst David Tamberrino saying he sees incremental risk to Tesla's business related to management's willingness to deploy capital for M&A, and he believes that any delay in the company's new Model 3 launch will be detrimental to shares. 2. JPMorgan (JPM) downgraded to Hold from Buy at Sandler O'Neill with analyst Jeffery Harte citing relative share outperformance. 3. Abercrombie & Fitch (ANF) downgraded to Sector Weight from Overweight at KeyBanc with analyst Jessica Schmidt saying the elevated promotions add to other headwinds, including the fact that the teen space is "overstored" and faces soft consumer demand and weak tourism. 4. American Express (AXP) downgraded to Reduce from Neutral at Nomura with analyst Bill Carcache saying the combination of weaker than expected revenues and higher than expected expenses will weigh on the shares. 5. Lowe's (LOW) downgraded to Neutral from Buy at Cleveland Research. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
BCS Barclays

09/21/16
09/21/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Monsanto (MON) upgraded to Overweight from Neutral at JPMorgan with analyst Jeffrey Zekauskas saying the risk in the shares is "less than what the market assumes." 2. Barclays (BCS) upgraded to Buy from Hold at HSBC citing the pending disposal of non-core businesses and resulting value creation. 3. Etsy (ETSY) upgraded to Buy from Neutral at Monness Crespi with the firm's analyst believing that Etsy shares can still move higher and sees a solid opportunity for upward revisions from improving conversion rates due to enhanced search and mobile functionality, expanding take rates, and advanced cross-boarder commerce capabilities with vendors. 4. Clovis (CLVS) upgraded to Outperform from Neutral at Credit Suisse with analyst Kennen MacKay saying the potential for a takeover "outweighs concerns surrounding patent life, limited experience in platinum resistant/refractory patients, and PARPi competition." 5. Jabil Circuit (JBL) upgraded to Buy from Neutral at UBS with analyst Steven Milunovich saying the company's cash flow is nearing an inflection amid an upturn in its Apple (AAPL) business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/21/16
HSBC
09/21/16
UPGRADE
HSBC
Buy
Barclays upgraded to Buy from Hold at HSBC
HSBC upgraded Barclays to Buy to reflect the pending disposal of non-core businesses and resulting value creation.
08/08/16
EXAN
08/08/16
UPGRADE
EXAN
Outperform
Barclays upgraded to Outperform from Neutral at Exane BNP Paribas
Exane BNP Paribas analyst Tom Rayner upgraded Barclays to Outperform with a GBP 205 price target citing valuation.
07/20/16
UBSW
07/20/16
DOWNGRADE
UBSW
Neutral
Barclays downgraded to Neutral from Buy at UBS
LYG Lloyds Banking
$2.82

-0.02 (-0.70%)

07/26/16
BREN
07/26/16
UPGRADE
BREN
Hold
Lloyds Banking upgraded to Hold from Sell at Berenberg
09/26/16
GSCO
09/26/16
DOWNGRADE
GSCO
Sell
Lloyds Banking downgraded to Sell from Neutral at Goldman
Goldman Sachs downgraded Lloyds Banking to Sell saying the current valuation does not price in future margin headwinds.
09/26/16
GSCO
09/26/16
DOWNGRADE
GSCO
Sell
Lloyds Banking downgraded to Sell from Neutral at Goldman
09/05/16
DBAB
09/05/16
DOWNGRADE
DBAB
Hold
Lloyds Banking downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst David Lock downgraded Lloyds Banking Group to Hold saying the "lower-for-longer" interest rate environment following the Brexit vote is a negative for the sector. Lock also downgraded RBS (RBS) this morning to Sell.
RBS RBS

08/08/16
MACQ
08/08/16
DOWNGRADE
MACQ
Neutral
RBS downgraded to Neutral from Outperform at Macquarie
Macquarie downgraded RBS to Neutral citng the recent strength in shares.
09/05/16
DBAB
09/05/16
DOWNGRADE
DBAB
Sell
RBS downgraded to Sell from Hold at Deutsche Bank
Deutsche Bank analyst David Lock downgraded Royal Bank of Scotland Group to Sell saying the "lower-for-longer" interest rate environment following the Brexit vote is a negative for the sector.
07/18/16
NTXS
07/18/16
DOWNGRADE
NTXS
Reduce
RBS downgraded to Reduce from Neutral at Natixis
WFC Wells Fargo
$45.18

0.19 (0.42%)

09/22/16
DBAB
09/22/16
NO CHANGE
Target $50
DBAB
Buy
Wells Fargo price target lowered to $50 from $59 at Deutsche Bank
Deutsche Bank analyst Matt O'Connor lowered his price target for Wells Fargo to $50 saying it's "tough to argue for much upside in the near term." The analyst, however, believes that over the next year, Wells Fargo's issues should subside and its "attractive valuation should be more relevant." After laying out the bull and bear thesis on the shares, O'Connor sees 5%-12% relative upside in the name. He keeps a Buy rating on Wells Fargo.
10/04/16
RAJA
10/04/16
DOWNGRADE
RAJA
Underperform
Wells Fargo downgraded to Underperform from Market Perform at Raymond James
Raymond James analyst David Long downgraded Wells Fargo to Underperform and reduced estimate saying the fallout from the unauthorized account openings will result in continued under performance. The analyst said several additional investigations, lawsuits, and fines have been announced, resulting in a still cloudy outlook.
10/04/16
10/04/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) downgraded to Underperform from Market Perform at Raymond James with analyst David Long saying the fallout from the unauthorized account openings will result in continued under performance. The analyst said several additional investigations, lawsuits, and fines have been announced, resulting in a still cloudy outlook. 2. Kinder Morgan (KMI) downgraded to Hold from Buy at Stifel analyst Selman Akyol citing valuation. 3. GrubHub (GRUB) downgraded to Hold from Buy at Stifel with analyst John Egbert citing valuation. 4. Dr Pepper Snapple (DPS) downgraded to Hold from Buy at Evercore ISI with analyst Robert Ottenstein saying reports that Bai Brands is looking for a new owner are credible and could change investor's psychology on the stock and its Allied Brands business. 5. Dollar Tree (DLTR) downgraded to Neutral from Buy at Cleveland Research with the firm saying sales trends appear to have slowed further at Family Dollar as the company struggles with increased price competition, difficult comps, and strategy headwinds. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

MOH

Molina Healthcare

$64.54

-0.78 (-1.19%)

, UNH

UnitedHealth

$191.75

-1.28 (-0.66%)

18:17
09/25/17
09/25
18:17
09/25/17
18:17
Hot Stocks
Senator Collins opposes Graham-Cassidy ACA repeal bill »

U.S. Senator Susan…

MOH

Molina Healthcare

$64.54

-0.78 (-1.19%)

UNH

UnitedHealth

$191.75

-1.28 (-0.66%)

CNC

Centene

$90.33

-1.89 (-2.05%)

WCG

WellCare

$164.15

-3.01 (-1.80%)

CI

Cigna

$181.44

-1.3 (-0.71%)

ANTM

Anthem

$181.50

-1.36 (-0.74%)

HNT

Health Net

HUM

Humana

$237.21

-1.88 (-0.79%)

AET

Aetna

$151.98

-1.59 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

18:15
09/25/17
09/25
18:15
09/25/17
18:15
General news
Breaking General news story  »

Minneapolis Federal…

CATM

Cardtronics

$26.10

-3.17 (-10.83%)

18:13
09/25/17
09/25
18:13
09/25/17
18:13
Downgrade
Cardtronics rating change  »

Cardtronics downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IVTY

Invuity

$7.80

-0.5 (-6.02%)

18:10
09/25/17
09/25
18:10
09/25/17
18:10
Recommendations
Invuity analyst commentary  »

Invuity's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Nov

MOH

Molina Healthcare

$64.54

-0.78 (-1.19%)

, UNH

UnitedHealth

$191.75

-1.28 (-0.66%)

18:05
09/25/17
09/25
18:05
09/25/17
18:05
Hot Stocks
CBO: Graham-Cassidy ACA repeal bill to reduce number of insured by 'millions' »

The Congressional Budget…

MOH

Molina Healthcare

$64.54

-0.78 (-1.19%)

UNH

UnitedHealth

$191.75

-1.28 (-0.66%)

CNC

Centene

$90.33

-1.89 (-2.05%)

WCG

WellCare

$164.15

-3.01 (-1.80%)

CI

Cigna

$181.44

-1.3 (-0.71%)

ANTM

Anthem

$181.50

-1.36 (-0.74%)

HNT

Health Net

HUM

Humana

$237.21

-1.88 (-0.79%)

AET

Aetna

$151.98

-1.59 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

GPC

Genuine Parts

$93.22

5.24 (5.96%)

18:04
09/25/17
09/25
18:04
09/25/17
18:04
Recommendations
Genuine Parts analyst commentary  »

Genuine Parts acquisition…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 19

    Oct

  • 30

    Oct

AA

Alcoa

$45.29

-0.09 (-0.20%)

, FCX

Freeport McMoRan

$13.89

-0.17 (-1.21%)

17:55
09/25/17
09/25
17:55
09/25/17
17:55
Recommendations
Alcoa, Freeport McMoRan, Teck Resources, Newmont Mining, Warrior Met Coal, Cleveland-Cliffs analyst commentary  »

Morgan Stanley raising…

AA

Alcoa

$45.29

-0.09 (-0.20%)

FCX

Freeport McMoRan

$13.89

-0.17 (-1.21%)

TECK

Teck Resources

$21.24

-0.72 (-3.28%)

NEM

Newmont Mining

$38.63

0.74 (1.95%)

HCC

Warrior Met Coal

$24.11

0.76 (3.25%)

CLF

Cleveland-Cliffs

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 02

    Oct

  • 20

    Oct

  • 26

    Oct

17:55
09/25/17
09/25
17:55
09/25/17
17:55
Conference/Events
Federal Reserve Bank of Minneapolis President participates in a discussion »

Minneapolis Federal…

FTK

Flotek

$5.40

0.04 (0.75%)

17:49
09/25/17
09/25
17:49
09/25/17
17:49
Earnings
Flotek cuts Q3 revenue view by $5M, consensus $90.9M »

Flotek announced impacts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 14

    Nov

  • 16

    May

NBLX

Noble Midstream

$54.11

3.75 (7.45%)

17:44
09/25/17
09/25
17:44
09/25/17
17:44
Recommendations
Noble Midstream analyst commentary  »

Noble Midstream guidance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 31

    Oct

FB

Facebook

$162.87

-7.67 (-4.50%)

17:38
09/25/17
09/25
17:38
09/25/17
17:38
Periodicals
Russia looked to 'exploit' divisions in U.S. populace with Facebook ads, WP says »

The collection of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

ASNA

Ascena Retail

$2.17

0.07 (3.33%)

, SNX

Synnex

$116.50

0.4 (0.34%)

17:35
09/25/17
09/25
17:35
09/25/17
17:35
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Ascena…

ASNA

Ascena Retail

$2.17

0.07 (3.33%)

SNX

Synnex

$116.50

0.4 (0.34%)

RHT

Red Hat

$105.76

-0.54 (-0.51%)

ACTA

Actua

$12.25

-0.1 (-0.81%)

PRQR

ProQR Therapeutics

$6.45

0.25 (4.03%)

GNCA

Genocea

$5.33

0.04 (0.76%)

KDMN

Kadmon

$3.79

0.27 (7.67%)

QEP

QEP Resources

$8.88

0.51 (6.09%)

TXMD

TherapeuticsMD

$6.06

-0.11 (-1.78%)

BIOP

Bioptix

$4.11

-0.16 (-3.75%)

CSGP

CoStar Group

$279.20

-1.62 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 27

    Sep

  • 16

    Oct

  • 17

    Oct

  • 03

    Nov

  • 26

    Sep

GKOS

Glaukos

$31.26

-0.93 (-2.89%)

17:30
09/25/17
09/25
17:30
09/25/17
17:30
Hot Stocks
Breaking Hot Stocks news story on Glaukos »

James E. Flynn reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIOP

Bioptix

$4.11

-0.16 (-3.75%)

17:28
09/25/17
09/25
17:28
09/25/17
17:28
Hot Stocks
Bioptix changes state of incorporation to Nevada from Colorado »

Bioptix said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$254.32

-2.13 (-0.83%)

17:26
09/25/17
09/25
17:26
09/25/17
17:26
Hot Stocks
Boeing and Qatar Airways announce order valued at $2.16B »

Boeing and Qatar Airways…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

CLXT

Calyxt

$26.54

0.82 (3.19%)

17:25
09/25/17
09/25
17:25
09/25/17
17:25
Hot Stocks
Calyxt: Herbicide-tolerant wheat, oil composition canola move to Phase 1 »

Calyxt announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

MNK

Mallinckrodt

$35.25

0.42 (1.21%)

17:03
09/25/17
09/25
17:03
09/25/17
17:03
Earnings
Mallinckrodt sees InfaCare acquisition 15c-20c dilutive to FY17 adjusted EPS »

Mallinckrodt announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Oct

FTI

TechnipFMC

$27.02

0.19 (0.71%)

17:02
09/25/17
09/25
17:02
09/25/17
17:02
Hot Stocks
TechnipFMC implements share repurchase of up to $500M »

TechnipFMC announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

GNCA

Genocea

$5.33

0.04 (0.76%)

17:01
09/25/17
09/25
17:01
09/25/17
17:01
Hot Stocks
Breaking Hot Stocks news story on Genocea 

Genocea trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

TXMD

TherapeuticsMD

$6.06

-0.11 (-1.78%)

16:53
09/25/17
09/25
16:53
09/25/17
16:53
Syndicate
TherapeuticsMD files to sell 12.4M shares of common stock »

J.P. Morgan is acting as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 03

    Nov

LLL

L3 Technologies

$189.32

0.04 (0.02%)

16:52
09/25/17
09/25
16:52
09/25/17
16:52
Hot Stocks
L3 Technologies files protest with GAO related to Fort Rucker contract »

L3 Technologies announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APRI

Apricus Biosciences

$1.73

0.05 (2.98%)

16:50
09/25/17
09/25
16:50
09/25/17
16:50
Syndicate
Apricus Biosciences requests withdrawal of registration statement »

The company confirms that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Feb

CDXS

Codexis

16:48
09/25/17
09/25
16:48
09/25/17
16:48
Hot Stocks
Breaking Hot Stocks news story on Codexis »

Vivo Ventures lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

  • 29

    Sep

  • 16

    Nov

AGRO

Adecogro

$10.05

-0.12 (-1.18%)

16:45
09/25/17
09/25
16:45
09/25/17
16:45
Hot Stocks
Adecoagro refinances majority of debt »

Adecoagro announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIBT

RiceBran

$1.21

-0.03 (-2.42%)

16:44
09/25/17
09/25
16:44
09/25/17
16:44
Hot Stocks
Breaking Hot Stocks news story on RiceBran »

Continental Grain reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.